Indaptus Therapeutics, Inc. (INDP) launched an amended at-the-market (ATM) equity offering. The company may sell up to $100 million of its common stock through the program. H.C. Wainwright & Co. will act as the sales agent for the offering.
This arrangement allows Indaptus to raise capital over time through open-market sales. The company maintains control over the timing, volume, and minimum price of all transactions.
Proceeds will be used to strengthen the balance sheet and fund general operations. The capital will also support the company's ongoing development programs.